Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called �antigens�). The technology behind the generation of monoclonal antibodies was discovered in 1972 by C�sar Milstein and Georges K�hler � scientists at the Roche-funded Basel Institute for Immunology � who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry. According to our (Global Info Research) latest study, the global Monoclonal Mouse Antibody market size was valued at USD 9246.8 million in 2022 and is forecast to a readjusted size of USD 12260 million by 2029 with a CAGR of 4.1% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. The key players are Roche, Johnson & Johnson, Merck, Novartis, AbbVie, Amgen, Pfizer, Bayer, Lilly, Bristol-Myers Squibb, GlaxoSmithKline, Biogen, AstraZeneca, Sanofi, Alexion Pharmaceuticals and Seattle Genetics, etc, with about 57% market shares. This report is a detailed and comprehensive analysis for global Monoclonal Mouse Antibody market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided. Key Features: Global Monoclonal Mouse Antibody market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029 Global Monoclonal Mouse Antibody market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029 Global Monoclonal Mouse Antibody market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029 Global Monoclonal Mouse Antibody market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023 The Primary Objectives in This Report Are: To determine the size of the total market opportunity of global and key countries To assess the growth potential for Monoclonal Mouse Antibody To forecast future growth in each product and end-use market To assess competitive factors affecting the marketplace This report profiles key players in the global Monoclonal Mouse Antibody market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Johnson & Johnson, Merck, Novartis and AbbVie, etc. This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence. Market Segmentation Monoclonal Mouse Antibody market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets. Market segment by Type IgM IgG IgA Others Market segment by Application Therapeutic Research Diagnostic ELISA kits Major players covered Roche Johnson & Johnson Merck Novartis AbbVie Amgen Pfizer Bayer Lilly Bristol-Myers Squibb GlaxoSmithKline Biogen AstraZeneca Sanofi Alexion Pharmaceuticals Seattle Genetics Market segment by region, regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe) Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia) South America (Brazil, Argentina, Colombia, and Rest of South America) Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa) The content of the study subjects, includes a total of 15 chapters: Chapter 1, to describe Monoclonal Mouse Antibody product scope, market overview, market estimation caveats and base year. Chapter 2, to profile the top manufacturers of Monoclonal Mouse Antibody, with price, sales, revenue and global market share of Monoclonal Mouse Antibody from 2018 to 2023. Chapter 3, the Monoclonal Mouse Antibody competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast. Chapter 4, the Monoclonal Mouse Antibody breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029. Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029. Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Monoclonal Mouse Antibody market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029. Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War. Chapter 13, the key raw materials and key suppliers, and industry chain of Monoclonal Mouse Antibody. Chapter 14 and 15, to describe Monoclonal Mouse Antibody sales channel, distributors, customers, research findings and conclusion.
1 Market Overview 1.1 Product Overview and Scope of Monoclonal Mouse Antibody 1.2 Market Estimation Caveats and Base Year 1.3 Market Analysis by Type 1.3.1 Overview: Global Monoclonal Mouse Antibody Consumption Value by Type: 2018 Versus 2022 Versus 2029 1.3.2 IgM 1.3.3 IgG 1.3.4 IgA 1.3.5 Others 1.4 Market Analysis by Application 1.4
